CFMB is a full agonist of FFAR2- and FFAR3-specific with EC 50 value of 0.8 μM target hFFAR2 and 0.2 μM target rFFAR2.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Free Fatty Acid Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.